Literature DB >> 9457454

A comparative study of the duration and efficacy of tetracaine 1% and bupivacaine 0.75% in controlling pain following photorefractive keratectomy (PRK).

S Verma1, M C Corbett, A Patmore, G Heacock, J Marshall.   

Abstract

OBJECTIVE: To evaluate if topical bupivacaine 0.75% provides better pain control after excimer laser over topical tetracaine 1% without affecting corneal wound healing, refractive outcome of visual function.
DESIGN: A prospective, double-masked trial was conducted in which 38 patients were randomized to receive either tetracaine or bupivacaine every 30 minutes for 24 hours post-operatively. Pain was recorded over a four day period using a Visual Analogue Pain Scale. The rate of epithelial healing was assessed during digitized retro-illumination photography. Visual performance was recorded using best corrected Snellen acuity, objective measurements of haze, halo and glare over a six month period.
RESULTS: Tetracaine afforded better pain control (p = 0.05). Full epithelial closure occurred in all patients within 72 hours and no statistically significant difference was recorded in any of the parameters measured.
CONCLUSIONS: Contrary to our expectation, the longer acting anaesthetic, bupivacaine, was inferior to tetracaine. Limited and supervised use of topical anaesthetics is recommended in controlling pain following photorefractive keratectomy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9457454     DOI: 10.1177/112067219700700404

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  6 in total

1.  Cytotoxic effect and possible mechanisms of Tetracaine on human corneal epithelial cells in vitro.

Authors:  Xin Pang; Ting-Jun Fan
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Efficacy and safety of three ophthalmic inserts for topical anaesthesia of the cornea. An exploratory comparative dose-ranging, double-blind, randomized trial in healthy volunteers.

Authors:  Isabelle Mahé; Stéphane Mouly; Irène Jarrin; Jacqueline Otéro; Catherine Tavera; Guy Simoneau; Yves Tillet; Robert Conti; Saïd El Meski; Alain Gaudric; Jean-François Bergmann
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

3.  Management of Ocular Trauma in Emergency (MOTE) Trial: A pilot randomized double-blinded trial comparing topical amethocaine with saline in the outpatient management of corneal trauma.

Authors:  Joseph Y S Ting; Kenneth J Barns; John L Holmes
Journal:  J Emerg Trauma Shock       Date:  2009-01

4.  Effect of Homatropine eye drops on pain after photorefractive keratectomy: A pilot study.

Authors:  Mahmoud Joshaghani; Hossein Nazari; Khalil Ghasemi Falavarjani; Siamak Shokrollahi; Mohammad Jafar Ghaempanah; Kaveh Abri Aghdam; Zahra Mirbolouk Jalali
Journal:  Saudi J Ophthalmol       Date:  2012-07-31

5.  Trichostatin a inhibits corneal haze in vitro and in vivo.

Authors:  Ajay Sharma; Maneesh M Mehan; Sunilima Sinha; John W Cowden; Rajiv R Mohan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-24       Impact factor: 4.799

6.  Comparison of the effect of cycloplegic versus NSAID eye drops on pain after photorefractive keratectomy.

Authors:  Kaveh Abri Aghdam; Hossein Aghaei; Siamak Shokrollahi; Mahmoud Joshaghani; Hossein Nazari; Masih Hashemi; Mohammad Jafar Ghaempanah
Journal:  J Curr Ophthalmol       Date:  2016-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.